The present invention provides the compound of Formulas I and its pharmaceutically acceptable salt, those inhibitors of voltage-gated sodium channels, especially Nav1.7. The compound can be used for treating and sodium channel activity such as pain, cough and itch. Additionally provide the pharmaceutical composition comprising the compound of the present invention.